Exemplis Discimus 2005, 149(2):449-453

Phasellus sit amet lectus sed eros aliquam ullamcorper..

Daxar Soduntisa, Bernarda Saira, Jianna Taraska, Hiram Felb, Jeanida Bishtoa
a Institute of Biological hematology, University of Bajic, Ansion Republic
b Clinic of Dermato-venerology, Faculty Hospital of Bajic, Republic of Naboo
Department of Child psychiatry, University of Sesswenna, Republic of Alderaan

Maecenas sem urna, condimentum porttitor, fringilla ac, vulputate et, dolor. Suspendisse quam nulla, fermentum eu, sagittis a, pulvinar id, lacus. Donec est leo, interdum ut, consectetuer eget, vulputate mattis, justo. Aliquam neque leo, rutrum nec, sagittis a, egestas in, felis. Donec tortor nisi, commodo ac, dictum quis, mollis eget, mauris. Nam augue mi, interdum sit amet, blandit eu, auctor rhoncus, eros. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Suspendisse accumsan velit non nisi blandit dapibus..

Keywords: Proin sit amet sem, Ut quis magna, Morbi in nisl, Phasellus tortor, Nulla facilisi

Received: June 10, 2005; Accepted: September 25, 2005; Published: December 1, 2005 

Open full article

References

  1. Stiborová M, Bieler CA, Wiessler M, Frei E. (2001) The anticancer agent ellipticine on activation by cytochrome P450 forms covalent DNA adducts. Biochem Pharmacol 62, 1675-184. Go to original source... Go to PubMed...
  2. Auclair C. (1987) Multimodal action of antitumor agents on DNA: The ellipticine series. Arch Biochem Biophys 259, 1-14. Go to original source... Go to PubMed...
  3. Singh MP, Hill GC, Peoch D, Rayner, B, Inabach, JL, Lown JW. (1994) High-field NMR and restrained molecular modeling studies on a DNA heteroduplex containing a modified apurinic abasic site in the form of covalently linked 9-aminoellipticine. Biochemistry 33, 10271-85. Go to original source... Go to PubMed...
  4. Chu Y, Hsu MT. (1992) Ellipticine increases the superhelical density of intracellular SV40 DNA by intercalation. Nucleic Acids Res 20, 4033-8. Go to original source... Go to PubMed...
  5. Monnot M, Mauffret O, Simon V, Lescot E, Psaume B, Saucier JM, Charra M, Belehradek JJr, Fermandjian S. (1991) DNA-drug recognition and effects on topoisomerase II-mediated cytotoxicity. A three-mode binding model for ellipticine derivatives. J Biol Chem 25, 1820-9.
  6. Fossé P, René B, Charra M, Paoletti C, Saucier JM. (1992) Stimulation of topoisomerase II-mediated DNA cleavage by ellipticine derivatives: structure-activity relationships. Mol Pharmacol 42, 590-5. Go to PubMed...
  7. Froelich-Ammon SJ, Patchan MW, Osheroff N, Thompson RB. (1995) Topoisomerase II binds to ellipticine in the absence or presence of DNA. Characterization of enzyme-drug interactions by fluorescence spectroscopy. J Biol Chem 270, 14998-5004. Go to original source... Go to PubMed...
  8. Frei E, Bieler CA, Arlt VM, Wiessler M, Stiborová M. (2002) Covalent binding of the anticancer drug ellipticine to DNA in V79 cells transfected with human cytochrome P450 enzymes. Biochem Pharmacol 64, 289-95. Go to original source... Go to PubMed...
  9. Stiborová M, Stiborová-Rupertová M, Boĝek-Dohalská L, Wiessler M, Frei E. (2003) Rat microsomes activating the anticancer drug ellipticine to species covalently binding to deoxyguanosine in DNA are a suitable model mimicking ellipticine bioactivation in humans. Chem Res Toxicol 16, 38-47. Go to original source... Go to PubMed...
  10. Stiborová M, Breuer A, Aimová D, Stiborová-Rupertová M, Wiessler M, Frei E. (2003) DNA adduct formation by the anticancer drug ellipticine in rats determined by 32P-postlabeling. Int J Cancer 107, 885-90. Go to original source... Go to PubMed...
  11. Murray GI., Weaver RJ, Paterson PJ, Ewen SW, Melvin WT, Burke MD. (1993) Expression of xenobiotic metabolizing enzymes in breast cancer. J Pathol 169, 347-53. Go to original source... Go to PubMed...
  12. Murray GI, Melvin WT, Burke M.(1995) Cytochrome P450 expression in tumors. J Pathol 3, 147-52. Go to original source... Go to PubMed...
  13. Patterson LH, McKeown SR, Robson T, Gallagher R, Raleigh SM, Orr S. (1999) Antitumor prodrug development using cytochrome P450 (CYP) mediated activation. Anti-Cancer Drug Design 14, 473-86. Go to PubMed...
  14. El-Rayes BF, Ali S, Heilbrun LK, Lababidi S, Bouwman S, Vischer D, Philip PA. (2003) Cytochrome P450 and glutathione transferase expression in human breast cancer. Clin Cancer Res 9, 1705-9. Go to PubMed...
  15. Stiborová M, Sejbal J, Boĝek-Dohalská L, Aimová D, Poljaková J, Forsterová K, Rupertová M, Wiesner J, Hudeèek J, Wiessler M, Frei E. (2004) The anticancer drug ellipticine forms covalent DNA adducts, mediated by human cytochromes P450, through metabolism to 13-hydroxyellipticine and ellipticine N2-oxide. Cancer Res 6, 8374-80. Go to original source... Go to PubMed...
  16. Boĝek-Dohalská L, Frei E, Stiborová M. (2004) DNA adduct formation by the anticancer drug ellipticine and its hydroxy derivatives in human breast adenocarcinoma MCF-7 cells. Collect Czech Chem Commun 69, 603-15. Go to original source...
  17. Poljaková J, Stiborová M. (2004) Peroxidase-mediated ellipticine- DNA adduct formation explains the selective efficiency of this anticancer drug against breast cancer and leukemia. Chem Listy 98, 298.
  18. Williams JA, Phillips DH. (2000) Mammary expression of xenobiotic metabolizing enzymes and their potential role in breast cancer. Cancer Res 60, 4667-77. Go to PubMed...
  19. Stiborová M., Hansíková H, Schmeiser HH, Frei. E. (1997) An investigation of the metabolism of N-nitrosodimethylamine and N-nitrosomethylaniline by horseradish peroxidase in vitro. Gen Physiol Biophys 16, 285-97. Go to PubMed...
  20. Stiborová M, Frei E, Schmeiser HH, Wiessler M, Hradec J. (1990) Mechanism of formation and 32P-postlabelling of DNA adducts derived from peroxidative activation of carcinogenic non-aminoazo dye 1-phenylazo-2-hydroxynaphthalene (Sudan I). Carcinogenesis 11, 1843-8. Go to original source... Go to PubMed...
  21. Stiborová M, Mikıanová M, Martínek V, Frei E. (2000) Heme peroxidases: structure, function, mechanism and involvement in activation of carcinogens. A review. Collect Czech Chem Commun 65, 297-325. Go to original source...
  22. Frei E, Borek-Dohalska L, Wiessler M, Stiborova M. (2001) Ellipticine forms covalent DNA adducts in rats with properties similar to adducts formed in vitro after activation by cytochrome P450 or peroxidases. Proc Am Assoc Cancer Res 42, 252.

Return to the content